Dashboard
Manage Tickers

CMRX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
WHO's Tedros Adhanom Ghebreyesus Posts On ...
04/11/2024 14:09:23

https://twitter.com/DrTedros/status/1778423967105139108  

hc-wainwright--co-reiterates-buy-on-chimerix-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Chim...
03/01/2024 12:14:30

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

chimerix-q4-cash-and-equivalents-204m
Chimerix Q4 Cash and Equivalents $204M
02/29/2024 12:06:07

chimerix-q4-eps-020-beats-024-estimate-sales-400k-miss-6000k-estimate
Chimerix Q4 EPS $(0.20) Beats $(0.24) Esti...
02/29/2024 12:05:32

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.24) by 1...

earnings-scheduled-for-february-29-2024
Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

preview-chimerixs-earnings
Preview: Chimerix's Earnings
02/28/2024 19:01:18

Core News & Articles
Reported Earlier, "WHO 'Very Worried' Abou...
12/08/2023 17:31:10

https://www.reuters.com/business/healthcare-pharmaceuticals/who-very-worried-about-spread-mpox-drc-2023-12-08/?taid=65734f21df0...

chimerix-announced-the-promotion-of-michelle-laspaluto-vice-president-of-corporate-financial-planning-and-investor-relations-to-chief-financial-officer-effective-december-1-2023
Chimerix Announced The Promotion Of Michel...
12/04/2023 12:17:53

chimerix-expects-to-end-2023-with-over-200m-in-cash-and-cash-equivalents-which-is-expected-to-be-sufficient-to-fund-operations-through-final-action-study-data-expected-in-2026
Chimerix Expects To End 2023 With Over $20...
11/02/2023 11:02:59

chimerix-q3-eps-027-misses-023-estimate-sales-1100k-may-not-be-comparable-to-8000k-estimate
Chimerix Q3 EPS $(0.27) Misses $(0.23) Est...
11/02/2023 11:01:32

Chimerix (NASDAQ: CMRX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.23) b...

earnings-scheduled-for-november-2-2023
Earnings Scheduled For November 2, 2023
11/02/2023 08:56:34

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...

earnings-outlook-for-chimerix
Earnings Outlook For Chimerix
11/01/2023 19:01:39

Core News & Articles
NetSol Technologies And 2 Other Stocks Und...
09/27/2023 13:14:46

The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidenc...

overview-of-value-stocks-in-the-healthcare-sector
Overview Of Value Stocks In The Healthcare...
09/18/2023 14:43:44

Core News & Articles
'CHP Investigates Two Confirmed Mpox Cases...
08/18/2023 13:00:09

https://www.info.gov.hk/gia/general/202308/18/P2023081800615.htm  

4-analysts-have-this-to-say-about-chimerix
4 Analysts Have This to Say About Chimerix
08/17/2023 20:00:18

wedbush-reiterates-outperform-on-chimerix-maintains-6-price-target
Wedbush Reiterates Outperform on Chimerix,...
08/17/2023 12:29:38

Wedbush analyst David Nierengarten reiterates Chimerix (NASDAQ:CMRX) with a Outperform and maintains $6 price target.

hc-wainwright--co-reiterates-buy-on-chimerix-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Chim...
08/16/2023 16:51:31

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

chimerix-announces-data-highlighting-clinical-efficacy-and-molecular-mechanisms-of-response-to-onc201-treatment-of-h3-k27m-mutant-diffuse-midline-gliomas-published-in-cancer-discovery
Chimerix Announces Data Highlighting Clini...
08/16/2023 14:07:18

Patients Treated with ONC201 Demonstrated Median Overall Survival (mOS) of 21.7 Months in the Front-Line Setting, Post Radiatio...

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
08/11/2023 18:01:50

  During the Friday's sesion, 157 stocks hit new 52-week lows.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION